Cellular and molecular mechanisms in the hypoxic tissue: Role of HIF-1 and ROS

Cell Biochemistry and Function

Volumn 31, Issue 6, 2013, Pages 451-459

  Zepeda, Andrea B ^a   Pessoa, Adalberto ^b   Castillo, Rodrigo L ^c   Figueroa, Carolina A ^a   Pulgar, Victor M ^d,e   Farías, Jorge G ^a  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CHILE   (Chile)

^d WINSTON SALEM STATE UNIVERSITY   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Hypoxia inducible factor (HIF 1); Hypoxic tissue; Nuclear factor B (NF B); Oxidative stress; Reactive oxygen species

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; NITRIC OXIDE; OXYGEN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN E;

ANGIOGENESIS; ARTICLE; ATMOSPHERE; ATOM; DNA BINDING; HYDROXYLATION; HYPOBARISM; HYPOXEMIA; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; MOLECULAR DYNAMICS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN SENSING; OXYGEN SUPPLY; PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REOXYGENATION; REPERFUSION INJURY; RESPIRATORY CHAIN; SPERMATOGENESIS; TISSUE METABOLISM; TRANSCRIPTION INITIATION; TUMOR MICROENVIRONMENT; UNFOLDED PROTEIN RESPONSE;

HYPOXIA-INDUCIBLE FACTOR (HIF-1); HYPOXIC TISSUE; NUCLEAR FACTOR ΚB (NF-ΚB); OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

ADENOSINE TRIPHOSPHATE; ANOXIA; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MITOCHONDRIA; OXYGEN; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84880329491     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2985     Document Type: Article

References (59)

1. Kwasiborski PJ, Kowalczyk P, Mrówka P, Kwasiborski M, Cwetsch A, Przybylski J. Selected biochemical markers of hypoxia. Przegl Lek 2012; 69: 115-119.
2. Acker T, Fandrey J, Acker H. The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolyl-hydroxylases. Cardiovasc Res 2006; 71: 195-207.
3. Dewhirs MW. Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress. Radiat Res 2009; 172: 653-665.
4. Rabbani ZN, Mi J, Zhang Y, et al. Hypoxia inducible factor 1α signaling in fractionated radiation induced lung injury: Role of oxidative stress and tissue hypoxia. Radiat Res 2010; 173: 165-174.
5. Brüne B, Zhou J. Nitric oxide and superoxide: interference with hypoxic signaling. Cardiovasc Res 2007; 75: 275-282.
6. Caramelo C, Peña JJ, Castilla A, et al. Respuesta a la hipoxia: Un mecanismo sistémico basado en el control de la expresión génica. Medicina 2006; 66: 155-164.
7. Reyes JG, Farias JG, Henríquez-Olavarrieta S, et al. The hypoxic testicle: physiology and pathophysiology. Oxid Med Cell Longev 2012; 2012: 929285.
8. Yoshimura M, Itasaka S, Harada H, Hiraoka M. Microenvironment and Radiation Therapy. BioMed Research International 2013; 2013:685308. DOI: 10.1155/2013/685308.
9. Li J, Wang JJ, Yu Q, Chen K, Mahadev K, Zhan SX. Inhibition of reactive oxygen species by lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice. Diabetes 2010; 59: 1528-1538.
10. Irwin DC, McCord JM, Nozik-Grayck E, et al. A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leak. Free Radic Biol Med 2009; 47: 55-61.
11. Harada H, Itasaka S, Kizaka-Kondoh S, et al. The Akt/mTOR pathway assures the synthesis of HIF-1alpha protein in a glucose- and reoxygenation-dependent manner in irradiated tumors. J Biol Chem 2009; 284: 5332-5342.
12. Douglas RM, Ryu J, Kanaan A, Rivero M, Dugan LL, Haddad GG. Neuronal death during combined intermittent hypoxia/hypercapnia is due to mitochondrial dysfunction. Am J Physiol Cell Physiol 2010; 298: C1594-C1602.
13. Bristow RG, Hill RP. Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 2008; 8: 180-192.
14. Kalliomäki TM, McCallum G, Lunt SJ, Wells PG, Hill RP. Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model. BMC Cancer 2008; 8: 151.
15. Rathore R, Zheng YM, Niu CF, et al. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCepsilon signaling axis in pulmonary artery smooth muscle cells. Free Radic Biol Med 2008; 45: 1223-1231.
16. Pan Y, Mansfield KD, Bertozzi CC, et al. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol Cell Biol 2007; 27: 912-925.
17. Kim JW, Johnson RS. You don't need a PHD to grow a tumor. Dev Cell 2009; 16: 781-782.
18. Muz B, Larsen H, Madden L, Kiriakidis S, Paleolog EM. Arthritis Prolyl hydroxylase domain enzyme 2 is the major player in regulating hypoxic responses in rheumatoid arthritis. Rheum 2012; 64: 2856-2867.
19. Liu YV, Baek JH, Zhang H, Diez R, Cole RN, Semenza GL. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol Cell 2007; 25: 207-217.
20. Liu YV, Semenza GL. RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization. Cell Cycle 2007; 6: 656-659.
21. Bonello S, Zähringer C, BelAiba RS, et al. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 2007; 27: 755-761.
22. Dewhirst MW, Cao Y, Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 2008; 8: 425-437.
23. Ayrapetov MK, Xu C, Sun Y, et al. Activation of Hif1α by the prolylhydroxylase inhibitor dimethyoxalyglycine decreases radiosensitivity. PLoS One 2011; 6: e26064.
24. Wan J, Chai H, Yu Z, et al. HIF-1α effects on angiogenic potential in human small cell lung carcinoma. J Exp Clin Cancer Res 2011; 15: 30-77.
25. Shapiro N, Yano K, Okada H, et al. A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock 2008; 29: 452-427.
26. Richters L, Lange N, Renner R, et al. Exercise-induced adaptations of cardiac redox homeostasis and remodeling in heterozygous SOD2-knockout mice. J Appl Physiol 2011; 111: 1431-1440.
27. Förstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 2010; 459: 923-939.
28. Hagen T, Taylor CT, Lam F, Moncada S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 2003; 302(5652): 1975-1978.
29. Santos CX, Anilkumar N, Zhang M, Brewer AC, Shah AM. Redox signaling in cardiac myocytes. Free Radic Biol Med 2011; 50: 777-793.
30. Diebold I, Petry A, Hess J, Görlach A. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol Biol Cell 2010; 21: 2087-2096.
31. Shimoda LA, Undem C. Interactions between calcium and reactive oxygen species in pulmonary arterial smooth muscle responses to hypoxia. Respir Physiol Neurobiol 2010; 174: 221-229.
32. Shifera AS. Protein-protein interactions involving IKKgamma (NEMO) that promote the activation of NF-kappaB. J Cell Physiol 2010; 223: 558-561.
33. Rius J, Guma M, Schachtrup C, et al. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 2008; 453: 807-811.
34. Wouters BG, Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 2008; 8: 851-864.
35. Murata R, Shibamoto Y, Sasai K, Oya N, Shibata T, Takagi T, Abe M. Reoxygenation after single irradiation in rodent tumors of different types and sizes. Int J Radiat Oncol Biol Phys 1996; 34: 859-865.
36. Moeller BJ, Cao Y, Li CY, Dewhirst MW. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004; 5: 429-441.
37. Hudson CC, Liu M, Chiang GG, et al. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol 2002; 22: 7004-7014.
38. Feldman DE, Chauhan V, Koong AC. The unfolded protein response: a novel component of the hypoxic stress response in tumors. Mol Cancer Res 2005; 3: 597-605.
39. Jansen G, Määttänen P, Denisov AY, et al. An interaction map of endoplasmic reticulum chaperones and foldases. Mol Cell Proteomics 2012; 11: 710-723.
40. Jonikas MC, Collins SR, Denic V, et al. Comprehensive characterization of genes required for protein folding in the endoplasmic reticulum. Science 2009; 323: 1693-1697.
41. Hebert DN, Molinari M. In and out of the ER: protein folding, quality control, degradation, and related human diseases. Physiol Rev 2007; 87: 1377-1408.
42. 2-dependent reaction cycle of Ero1-mediated oxidative protein folding in the endoplasmic reticulum. Mol Cell 2002; 10: 983-994.
43. Tu BP, Weissman JS. Oxidative protein folding in eukaryotes: mechanisms and consequences. J Cell Biol 2004; 164: 341-346.
44. Feldman DE, Chauhan V, Koong AC. The unfolded protein response: a novel component of the hypoxic stress response in tumors. Mol Cancer Res 2005; 3: 597-605.
45. Dewhirst MW. Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress. Radiat Res 2009; 72: 653-65.
46. Bailey KM, Wojtkowiak JW, Hashim AI, Gillies RJ. Targeting the metabolic microenvironment of tumors. Adv Pharmacol 2012; 65: 63-107.
47. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007; 59: 418-458.
48. Liu C, Xie G, Huang W, Yang Y, Li P, Tu Z. Elevated serum myeloperoxidase activities are significantly associated with the prevalence of ACS and high LDL-C levels in CHD patients. J Atheroscler Thromb 2012; 9: 435-43.
49. Rodrigo R, Prieto JC, Castillo R. Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n-3 fatty acids: molecular mechanisms and potential clinical applications. Clin Sci (Lond) 2013; 124: 1-15.
50. Belaidi E, Beguin PC, Levy P, Ribuot C, Godin-Ribuot D. Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat. Am J Physiol Heart Circ Physiol 2008; 294: H901-H908.
51. Cai Z, Zhong H, Bosch-Marce M, et al. Complete loss of ischemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha. Cardiovasc Res 2008; 77: 463-470.
52. Cai Z, Manalo DJ, Wei G, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003; 108: 79-85.
53. Farías JG, Zepeda AB, Calaf GM. Melatonin protects the heart, lungs and kidneys from oxidative stress under intermittent hypobaric hypoxia in rats. Biol Res 2012; 45: 81-85.
54. Hogan AM, Virues-Ortega J, Botti AB, et al. Development of aptitude at altitude. Dev Sci 2010; 13: 533-544.
55. Farias JG, Bustos-Obregón E, Tapia PJ, et al. Time course of endocrine changes in the hypophysis-gonad axis induced by hypobaric hypoxia in male rats. J Reprod Dev 2008; 54: 18-21.
56. Bohuslavová R, Kolář F, Kuthanová L, Neckář J, Tichopád A, Pavlinkova G. Gene expression profiling of sex differences in HIF1-dependent adaptive cardiac responses to chronic hypoxia. J Appl Physiol 2010; 109: 1195-1202.
57. Hainsworth R, Drinkhill MJ. Cardiovascular adjustments for life at high altitude. Respir Physiol Neurobiol 2007; 158: 204-211.
58. Farías JG, Jimenez D, Osorio J, Zepeda AB, Figueroa CA, Pulgar VM. Acclimatization to chronic intermittent hypoxia in mine workers: a challenge to mountain medicine in Chile. Biol Res 2013; 46: 59-67.
59. Qutub AA, Popel AS. Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia. Mol Cell Biol 2008; 28: 5106-5119.